Marathon Trading Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-17,764
Closed -$155K 352
2025
Q2
$155K Sell
17,764
-36,236
-67% -$263K 0.02% 199
2025
Q1
$430K Buy
54,000
+42,000
+350% +$425K 0.06% 149
2024
Q4
$109K Sell
12,000
-3,000
-20% -$29K 0.01% 244
2024
Q3
$138K Sell
15,000
-8,000
-35% -$66.2K 0.01% 210
2024
Q2
$225K Sell
23,000
-11,000
-32% -$134K 0.02% 179
2024
Q1
$513K Buy
+34,000
New +$617K 0.04% 160
2023
Q3
Sell
-20,000
Closed -$506K 356
2023
Q2
$506K Buy
+20,000
New +$503K 0.04% 125
2021
Q2
Sell
-1,731
Closed -$280K 399
2021
Q1
$315K Buy
1,731
+131
+8% +$30.4K 0.03% 260
2020
Q4
$320K Buy
+1,600
New +$325K 0.02% 278

Other funds holding TDOC

Marathon Trading Investment Management's TDOC Position: Q3 2025 in Review

Marathon Trading Investment Management sold out of Teladoc Health (TDOC) in Q3 2025, closing a stake of 17,764 shares — an estimated $155K sold.

Marathon Trading Investment Management first reported a position in TDOC in Q4 2020 and held it in 9 quarters. The position peaked at $513K in Q1 2024. 356 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

  • Marathon Trading Investment Management reported no remaining Teladoc Health position as of Q3 2025 after selling out during the quarter.
  • Marathon Trading Investment Management sold 17,764 Teladoc Health shares in Q3 2025, an estimated $155K.
  • Marathon Trading Investment Management first reported a position in Teladoc Health in Q4 2020 and held it in 9 quarters.
  • Marathon Trading Investment Management's Teladoc Health position peaked at $513K in Q1 2024.
  • 356 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on Marathon Trading Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.